Minerva Advisors LLC Raises Stock Holdings in Utah Medical Products, Inc. (NASDAQ:UTMD)

Minerva Advisors LLC boosted its holdings in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 85.2% during the fourth quarter, HoldingsChannel.com reports. The firm owned 78,389 shares of the medical instruments supplier’s stock after purchasing an additional 36,061 shares during the period. Utah Medical Products makes up approximately 2.8% of Minerva Advisors LLC’s holdings, making the stock its 12th largest holding. Minerva Advisors LLC’s holdings in Utah Medical Products were worth $4,819,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of UTMD. Rice Hall James & Associates LLC boosted its position in Utah Medical Products by 24.3% during the third quarter. Rice Hall James & Associates LLC now owns 83,338 shares of the medical instruments supplier’s stock worth $5,576,000 after purchasing an additional 16,297 shares in the last quarter. GSA Capital Partners LLP purchased a new position in Utah Medical Products during the third quarter worth approximately $231,000. Victory Capital Management Inc. boosted its position in Utah Medical Products by 439.0% during the third quarter. Victory Capital Management Inc. now owns 14,408 shares of the medical instruments supplier’s stock worth $964,000 after purchasing an additional 11,735 shares in the last quarter. Bard Associates Inc. boosted its position in Utah Medical Products by 1.1% during the third quarter. Bard Associates Inc. now owns 19,781 shares of the medical instruments supplier’s stock worth $1,329,000 after purchasing an additional 224 shares in the last quarter. Finally, Seizert Capital Partners LLC boosted its position in Utah Medical Products by 58.3% during the third quarter. Seizert Capital Partners LLC now owns 5,736 shares of the medical instruments supplier’s stock worth $384,000 after purchasing an additional 2,112 shares in the last quarter. Hedge funds and other institutional investors own 69.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 7th.

Utah Medical Products Price Performance

NASDAQ UTMD opened at $60.09 on Tuesday. The company has a market cap of $203.83 million, a PE ratio of 15.21 and a beta of 0.08. The stock’s 50 day simple moving average is $61.42 and its 200-day simple moving average is $64.41. Utah Medical Products, Inc. has a 1-year low of $58.87 and a 1-year high of $77.33.

Utah Medical Products (NASDAQ:UTMD) last released its earnings results on Tuesday, January 28th. The medical instruments supplier reported $0.86 earnings per share for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%.

Utah Medical Products Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, April 3rd. Stockholders of record on Friday, March 14th will be given a $0.305 dividend. The ex-dividend date is Friday, March 14th. This represents a $1.22 annualized dividend and a dividend yield of 2.03%. Utah Medical Products’s dividend payout ratio (DPR) is presently 30.89%.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.